[HTML][HTML] Interpretation and impact of real-world clinical data for the practicing clinician

L Blonde, K Khunti, SB Harris, C Meizinger… - Advances in …, 2018 - Springer
Real-world studies have become increasingly important in providing evidence of treatment
effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold …

Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical …

G Agiostratidou, H Anhalt, D Ball, L Blonde… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE To identify and define clinically meaningful type 1 diabetes outcomes beyond
hemoglobin A 1c (HbA 1c ) based upon a review of the evidence, consensus from clinical …

Gaps and barriers in the control of blood glucose in people with type 2 diabetes

L Blonde, P Aschner, C Bailey, L Ji… - Diabetes and …, 2017 - journals.sagepub.com
Background: Glycaemic control is suboptimal in a large proportion of people with type 2
diabetes who are consequently at an increased and avoidable risk of potentially severe …

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

…, E Montanya, JH Brett, M Zychma, L Blonde - The Lancet, 2009 - thelancet.com
Background Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor
agonists have a glucose-dependent action and promote weight loss. We compared the …

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD …

…, P Raskin, PM Hale, M Zdravkovic, L Blonde… - Diabetes …, 2009 - Am Diabetes Assoc
OBJECTIVE To determine the efficacy and safety of liraglutide (a glucagon-like peptide-1
receptor agonist) when added to metformin and rosiglitazone in type 2 diabetes. RESEARCH …

AACE comprehensive diabetes management algorithm 2013

…, JI Barzilay, L Blonde… - … : official journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
… Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T
Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn …

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

HW Rodbard, L Blonde… - … : official journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
… Helena W Rodbard, Lawrence Blonde, Susan S Braithwaite, Elise M Brett, Rhoda H
Cobin, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, Lois G Jovanovic, Philip …

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive …

Y Handelsman, JI Mechanick, L Blonde, G Grunberger… - Endocrine practice, 2011 - Elsevier
Lawrence Blonde reports that he has received speaker honoraria from AstraZeneca, Boehringer
Ingelheim Pharmaceuticals, Inc, Bristol-Myers Squibb, Daiichi Sankyo, Inc, Merck & Co, …

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …

…, D Einhorn, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2020 - Elsevier
Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical
Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control …

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …

AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2017 - Elsevier
Abbreviations: A1C = hemoglobin A1C AACE = American Association of Clinical Endocrinologists
ACCORD = Action to Control Cardiovascular Risk in Diabetes ACCORD BP = Action …